Table 1.
A summary of the different types of Intraductal Papillary Mucinous Neoplasms (IPMN; 15–33).
| IPMN Type | Location in Pancreas | IPMN Duct Location | Mucin Expression | Invasion Rate | Invasive Subtype—% | Recurrence Rate | 5-Year Survival |
|---|---|---|---|---|---|---|---|
| Gastric | Head (uncinate), periphery | BD & MD | MUC1-, MUC2-, MUC5AC+, MUC6+ | 9.4% | tubular—30.8% | 7.9–15.3% | 70–93.7% |
| Intestinal | Head | MD | MUC1-, MUC2+, MUC5AC+, CDX2+ | 41.6% | colloid—55.6% | 19.8–24.4% | 86.6–88.6% |
| Pancreatico-biliary | Head | MD | MUC1+, MUC2-, MUC5AC+, CDX2- | 63.2% | tubular—90.2% | 31.6–70.7% | 35.6–52.0% |
| Oncocytic | Head | MD | MUC1+, MUC2-, MUC5AC+ | 45.8% | oncocytic—75% | 12.5–25% | 75–100% |
BD: Branch Duct; MD: Main Duct.